Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.
Antonsen KK, Klausen MK, Brunchmann AS, le Dous N, Jensen ME, Miskowiak KW, Fisher PM, Thomsen GK, Rindom H, Fahmy TP, Vollstaedt-Klein S, Benveniste H, Volkow ND, Becker U, Ekstrøm C, Knudsen GM, Vilsbøll T, Fink-Jensen A. Antonsen KK, et al. Among authors: klausen mk. BMJ Open. 2018 Jul 16;8(7):e019562. doi: 10.1136/bmjopen-2017-019562. BMJ Open. 2018. PMID: 30012779 Free PMC article.
Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.
Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, Fink-Jensen A. Jensen ME, et al. Among authors: klausen mk. Neurochem Int. 2020 Sep;138:104772. doi: 10.1016/j.neuint.2020.104772. Epub 2020 May 25. Neurochem Int. 2020. PMID: 32464226 Free PMC article.
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial.
Klausen MK, Jensen ME, Møller M, Le Dous N, Jensen AØ, Zeeman VA, Johannsen CF, Lee A, Thomsen GK, Macoveanu J, Fisher PM, Gillum MP, Jørgensen NR, Bergmann ML, Enghusen Poulsen H, Becker U, Holst JJ, Benveniste H, Volkow ND, Vollstädt-Klein S, Miskowiak KW, Ekstrøm CT, Knudsen GM, Vilsbøll T, Fink-Jensen A. Klausen MK, et al. JCI Insight. 2022 Oct 10;7(19):e159863. doi: 10.1172/jci.insight.159863. JCI Insight. 2022. PMID: 36066977 Free PMC article. Clinical Trial.